APA (7th ed.) Citation

Palmer, B. F., & Clegg, D. J. (2021). Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy. Clinical journal of the American Society of Nephrology, 16(8), 1284. https://doi.org/10.2215/CJN.17621120

Chicago Style (17th ed.) Citation

Palmer, Biff F., and Deborah J. Clegg. "Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy." Clinical Journal of the American Society of Nephrology 16, no. 8 (2021): 1284. https://doi.org/10.2215/CJN.17621120.

MLA (9th ed.) Citation

Palmer, Biff F., and Deborah J. Clegg. "Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy." Clinical Journal of the American Society of Nephrology, vol. 16, no. 8, 2021, p. 1284, https://doi.org/10.2215/CJN.17621120.